Talking Medicines

United Kingdom
Hollinwood, England, United Kingdom, G5 8BP

Company profile

Talking Medicines company profile

Talking Medicines provides Pharma and Med Comms agencies with AI-powered intelligence to measure, predict, and prove the impact of scientific messaging on HCPs. Using proprietary platforms, DrugVoice and the Message Resonance Score™, the company addresses a $23Bn marketing blind spot, connecting messaging to real-world prescribing behaviour. Its domain-specific data science enables clients to optimise campaigns, de-risk marketing investment, and demonstrate measurable ROI, positioning Talking Medicines as a strategic, high-value solution in the life sciences marketing ecosystem.

Business identity

Contact email
[email protected]
Phone number
00 44 141 222 2212
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2013-04-10

Headquarters

Postal code
G5 8BP
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
4
Total equity funding
$4.3M
Last funding
Series Unknown / $2M / 2022-02-01
Last equity funding
Series Unknown / $2M
Investors
6
Lead investors
2
Founders
3
Articles
23

Founders and investors

Founders

Elizabeth FairleyJo HallidayScott Crae

Lead investors

SIS VenturesTern

Investors

Rob DobsonScottish EnterpriseScottish Investment BankSIS VenturesTern